248 related articles for article (PubMed ID: 10509609)
21. Leptin and melanocortin signaling in the hypothalamus.
Bjørbaek C; Hollenberg AN
Vitam Horm; 2002; 65():281-311. PubMed ID: 12481551
[TBL] [Abstract][Full Text] [Related]
22. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein.
Ollmann MM; Wilson BD; Yang YK; Kerns JA; Chen Y; Gantz I; Barsh GS
Science; 1997 Oct; 278(5335):135-8. PubMed ID: 9311920
[TBL] [Abstract][Full Text] [Related]
23. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides.
Tatro JB
Neuroimmunomodulation; 1996; 3(5):259-84. PubMed ID: 9218248
[TBL] [Abstract][Full Text] [Related]
24. Molecular pharmacology of Agouti protein in vitro and in vivo.
Barsh GS; Ollmann MM; Wilson BD; Miller KA; Gunn TM
Ann N Y Acad Sci; 1999 Oct; 885():143-52. PubMed ID: 10816647
[TBL] [Abstract][Full Text] [Related]
25. Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice.
Hoggard N; Rayner DV; Johnston SL; Speakman JR
J Mol Endocrinol; 2004 Dec; 33(3):693-703. PubMed ID: 15591028
[TBL] [Abstract][Full Text] [Related]
26. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice.
Shutter JR; Graham M; Kinsey AC; Scully S; Lüthy R; Stark KL
Genes Dev; 1997 Mar; 11(5):593-602. PubMed ID: 9119224
[TBL] [Abstract][Full Text] [Related]
27. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo.
Rossi M; Kim MS; Morgan DG; Small CJ; Edwards CM; Sunter D; Abusnana S; Goldstone AP; Russell SH; Stanley SA; Smith DM; Yagaloff K; Ghatei MA; Bloom SR
Endocrinology; 1998 Oct; 139(10):4428-31. PubMed ID: 9751529
[TBL] [Abstract][Full Text] [Related]
28. [Psychiatric disorders and neural mechanisms underlying energy intake and expenditure: a review].
Kishi T; Horiguchi J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Oct; 23(5):197-203. PubMed ID: 14653225
[TBL] [Abstract][Full Text] [Related]
29. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
[TBL] [Abstract][Full Text] [Related]
30. Melanocortin-4 receptor: a novel signalling pathway involved in body weight regulation.
Fisher SL; Yagaloff KA; Burn P
Int J Obes Relat Metab Disord; 1999 Feb; 23 Suppl 1():54-8. PubMed ID: 10193863
[TBL] [Abstract][Full Text] [Related]
31. Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system.
Adan RA
Trends Pharmacol Sci; 2006 Apr; 27(4):183-6. PubMed ID: 16500715
[TBL] [Abstract][Full Text] [Related]
32. Liver-specific expression of the agouti gene in transgenic mice promotes liver carcinogenesis in the absence of obesity and diabetes.
Kuklin AI; Mynatt RL; Klebig ML; Kiefer LL; Wilkison WO; Woychik RP; Michaud EJ
Mol Cancer; 2004 Jun; 3():17. PubMed ID: 15175105
[TBL] [Abstract][Full Text] [Related]
33. Effects of a potent melanocortin agonist on the diabetic/obese phenotype in yellow mice.
Zemel MB; Moore JW; Moustaid N; Kim JH; Nichols JS; Blanchard SG; Parks DJ; Harris C; Lee FW; Grizzle M; James M; Wilkison WO
Int J Obes Relat Metab Disord; 1998 Jul; 22(7):678-83. PubMed ID: 9705029
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of melanin-concentrating hormone and orexin genes in the agouti-related protein/melanocortin-4 receptor system.
Hanada R; Nakazato M; Matsukura S; Murakami N; Yoshimatsu H; Sakata T
Biochem Biophys Res Commun; 2000 Feb; 268(1):88-91. PubMed ID: 10652218
[TBL] [Abstract][Full Text] [Related]
35. Effect of Agouti-related protein in regulation of the hypothalamic-pituitary-thyroid axis in the melanocortin 4 receptor knockout mouse.
Fekete C; Marks DL; Sarkar S; Emerson CH; Rand WM; Cone RD; Lechan RM
Endocrinology; 2004 Nov; 145(11):4816-21. PubMed ID: 15256492
[TBL] [Abstract][Full Text] [Related]
36. Mouse models of obesity.
Carroll L; Voisey J; van Daal A
Clin Dermatol; 2004; 22(4):345-9. PubMed ID: 15475237
[TBL] [Abstract][Full Text] [Related]
37. The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box.
Williams G; Harrold JA; Cutler DJ
Proc Nutr Soc; 2000 Aug; 59(3):385-96. PubMed ID: 10997654
[TBL] [Abstract][Full Text] [Related]
38. Leptin infusion and obesity in mouse cause alterations in the hypothalamic melanocortin system.
Gout J; Sarafian D; Tirard J; Blondet A; Vigier M; Rajas F; Mithieux G; Begeot M; Naville D
Obesity (Silver Spring); 2008 Aug; 16(8):1763-9. PubMed ID: 18551122
[TBL] [Abstract][Full Text] [Related]
39. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation.
Cone RD; Lu D; Koppula S; Vage DI; Klungland H; Boston B; Chen W; Orth DN; Pouton C; Kesterson RA
Recent Prog Horm Res; 1996; 51():287-317; discussion 318. PubMed ID: 8701084
[TBL] [Abstract][Full Text] [Related]
40. Melanocortins and their receptors and antagonists.
Voisey J; Carroll L; van Daal A
Curr Drug Targets; 2003 Oct; 4(7):586-97. PubMed ID: 14535656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
